Register
Consensus recommendations on the use of SUs in type 2 diabetes |
Journal Updates
eMediNexus Coverage from: 
Consensus recommendations on the use of SUs in type 2 diabetes
eMediNexus,  16 March 2018
remove_red_eye 863 Views
#Diabetes and Endocrinology #Internal Medicine #Pharmacist

0 Read Comments                

Consensus recommendations from International Task Force on the use of sulfonylureas (SUs) and sulfonylureas in combination with other glucose-lowering drugs in the management of type 2 diabetes mellitus are published in the January-February 2018 issue of the Indian Journal of Endocrinology and Metabolism.
To continue reading this article
Sign in with Medtalks

Continue reading your article with a eMediNexus account.
Free Membership!